List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Model Organism Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Model Organism Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Model Organism Overall Market Size
2.1 Global Model Organism Market Size: 2023 VS 2029
2.2 Global Model Organism Market Size, Prospects & Forecasts: 2023-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Model Organism Players in Global Market
3.2 Global Companies Model Organism Product & Technology
4 Model Organism Companies Profiles
4.1 Shanghai Model Organisms Center, Inc.
4.1.1 Shanghai Model Organisms Center, Inc. Company Summary
4.1.2 Shanghai Model Organisms Center, Inc. Business Overview
4.1.3 Shanghai Model Organisms Center, Inc. Model Organism Product Offerings & Technology
4.1.4 Shanghai Model Organisms Center, Inc. Model Organism R&D, and Plans
4.2 Gem Pharmatech Co., Ltd.
4.2.1 Gem Pharmatech Co., Ltd. Company Summary
4.2.2 Gem Pharmatech Co., Ltd. Business Overview
4.2.3 Gem Pharmatech Co., Ltd. Model Organism Product Offerings & Technology
4.2.4 Gem Pharmatech Co., Ltd. Model Organism R&D, and Plans
4.3 Charles River Laboratories
4.3.1 Charles River Laboratories Company Summary
4.3.2 Charles River Laboratories Business Overview
4.3.3 Charles River Laboratories Model Organism Product Offerings & Technology
4.3.4 Charles River Laboratories Model Organism R&D, and Plans
4.4 Envigo
4.4.1 Envigo Company Summary
4.4.2 Envigo Business Overview
4.4.3 Envigo Model Organism Product Offerings & Technology
4.4.4 Envigo Model Organism R&D, and Plans
4.5 Taconic Biosciences
4.5.1 Taconic Biosciences Company Summary
4.5.2 Taconic Biosciences Business Overview
4.5.3 Taconic Biosciences Model Organism Product Offerings & Technology
4.5.4 Taconic Biosciences Model Organism R&D, and Plans
4.6 Jackson Laboratory
4.6.1 Jackson Laboratory Company Summary
4.6.2 Jackson Laboratory Business Overview
4.6.3 Jackson Laboratory Model Organism Product Offerings & Technology
4.6.4 Jackson Laboratory Model Organism R&D, and Plans
4.7 Shanghai SLAC
4.7.1 Shanghai SLAC Company Summary
4.7.2 Shanghai SLAC Business Overview
4.7.3 Shanghai SLAC Model Organism Product Offerings & Technology
4.7.4 Shanghai SLAC Model Organism R&D, and Plans
4.8 Joinn Laboratories
4.8.1 Joinn Laboratories Company Summary
4.8.2 Joinn Laboratories Business Overview
4.8.3 Joinn Laboratories Model Organism Product Offerings & Technology
4.8.4 Joinn Laboratories Model Organism R&D, and Plans
4.9 Crown Biosciences
4.9.1 Crown Biosciences Company Summary
4.9.2 Crown Biosciences Business Overview
4.9.3 Crown Biosciences Model Organism Product Offerings & Technology
4.9.4 Crown Biosciences Model Organism R&D, and Plans
4.10 Pharmalegacy
4.10.1 Pharmalegacy Company Summary
4.10.2 Pharmalegacy Business Overview
4.10.3 Pharmalegacy Model Organism Product Offerings & Technology
4.10.4 Pharmalegacy Model Organism R&D, and Plans
4.11 Syngene International
4.11.1 Syngene International Company Summary
4.11.2 Syngene International Business Overview
4.11.3 Syngene International Model Organism Product Offerings & Technology
4.11.4 Syngene International Model Organism R&D, and Plans
4.12 Janvier Labs
4.12.1 Janvier Labs Company Summary
4.12.2 Janvier Labs Business Overview
4.12.3 Janvier Labs Model Organism Product Offerings & Technology
4.12.4 Janvier Labs Model Organism R&D, and Plans
4.13 GenOway
4.13.1 GenOway Company Summary
4.13.2 GenOway Business Overview
4.13.3 GenOway Model Organism Product Offerings & Technology
4.13.4 GenOway Model Organism R&D, and Plans
4.14 Psychogenics
4.14.1 Psychogenics Company Summary
4.14.2 Psychogenics Business Overview
4.14.3 Psychogenics Model Organism Product Offerings & Technology
4.14.4 Psychogenics Model Organism R&D, and Plans
4.15 Horizon Discovery Group
4.15.1 Horizon Discovery Group Company Summary
4.15.2 Horizon Discovery Group Business Overview
4.15.3 Horizon Discovery Group Model Organism Product Offerings & Technology
4.15.4 Horizon Discovery Group Model Organism R&D, and Plans
4.16 Vitalstar Biotechnology
4.16.1 Vitalstar Biotechnology Company Summary
4.16.2 Vitalstar Biotechnology Business Overview
4.16.3 Vitalstar Biotechnology Model Organism Product Offerings & Technology
4.16.4 Vitalstar Biotechnology Model Organism R&D, and Plans
5 Sights by Region
5.1 By Region - Global Model Organism Market Size, 2024 & 2029
5.2 By Region - Global Model Organism Revenue, (2024-2029)
5.3 United States
5.3.1 Key Players of Model Organism in United States
5.3.2 United States Model Organism Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Model Organism in Europe
5.4.2 Europe Model Organism Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Model Organism in China
5.5.2 China Model Organism Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Model Organism Market Size Markets, 2024 & 2029
6.2 Prokaryote
6.3 Eukaryote
7 Sights by Application
7.1 By Application - Global Model Organism Market Size, 2024 & 2029
7.2 Drug Discovery
7.3 Basic Research
7.4 Toxicity Test
7.5 Parasitological Study
7.6 Hereditary Disease Study
7.7 Others
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
